PARATEK PHARMACEUTICALS INC (PRTK)

US6993743029 - Common Stock

2.23  +0.04 (+1.83%)

After market: 2.23 0 (0%)

Full estimates are only available for subscribed users, you can see which data is available below.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030
Revenue
YoY % growth
46.92M
183.68%		130.162M
177.41%		160.268M
23.13%		166.13M
3.66%
EBITDA
YoY % growth
-74.92M-40.739M
45.62%		-45.719M
-12.22%		N/AN/AN/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
-75.5M
34.71%		-41.13M
45.52%		-46.209M
-12.35%		-36.641M
20.71%
Operating Margin
-160.91%-31.60%-28.83%-22.06%
EPS
YoY % growth
-2.25
42.75%		-1.22
45.78%		-1.18
3.28%		-0.80
32.14%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q3 / 23 Q4 / 23 Q1 / 24 Q2 / 24 Q3 / 24 Q4 / 24
EPS
Q2Q % growth		-0.25
34.24%
Revenue
Q2Q % growth		39.602M
31.08%
EBITDA
Q2Q % growth		N/AN/AN/AN/AN/AN/A
EBIT
Q2Q % growth		-9.91M
39.91%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q2 2023
Q2Q % growth		 -0.25
24.24%		-0.320.0721.78%
Q1 2023
Q2Q % growth		 -0.35 -0.430.0818.30%
Q4 2022
Q2Q % growth		 -0.12
81.82%		0.10-0.22-226.05%
Q3 2022
Q2Q % growth		 -0.38
-2.70%		-0.30-0.08-28.47%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q2 2023
Q2Q % growth		 39.993M
34.94%		34.527M5.466M15.83%
Q1 2023
Q2Q % growth		 31.236M
25.64%		30.685M551K1.80%
Q4 2022
Q2Q % growth		 75.557M
137.62%		64.724M10.833M16.74%
Q3 2022
Q2Q % growth		 30.213M
23.59%		34.876M-4.663M-13.37%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% 6.96% 14.05% 22.02%
Revenue0% 1.68% 3.71% 5.86%